These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 21892200

  • 1. Modulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans.
    Liu L, Pan X, Liu HY, Liu XD, Yang HW, Xie L, Cheng JL, Fan HW, Xiao DW.
    Acta Pharmacol Sin; 2011 Oct; 32(10):1285-93. PubMed ID: 21892200
    [Abstract] [Full Text] [Related]

  • 2. A physiologically based pharmacokinetic model characterizing mechanism-based inhibition of CYP1A2 for predicting theophylline/antofloxacin interaction in both rats and humans.
    Pan X, Wang P, Hu N, Liu L, Liu X, Xie L, Wang G.
    Drug Metab Pharmacokinet; 2011 Oct; 26(4):387-98. PubMed ID: 21512260
    [Abstract] [Full Text] [Related]

  • 3. The influence of a newly developed quinolone: antofloxacin, on CYP activity in rats.
    Xu X, Liu HY, Liu L, Xie L, Liu XD.
    Eur J Drug Metab Pharmacokinet; 2008 Oct; 33(1):1-7. PubMed ID: 18543578
    [Abstract] [Full Text] [Related]

  • 4. Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats.
    Zhu Q, Liao J, Xie L, Wang GJ, Liu XD.
    Xenobiotica; 2009 Apr; 39(4):293-301. PubMed ID: 19350452
    [Abstract] [Full Text] [Related]

  • 5. Effect of alosetron on theophylline pharmacokinetics.
    Koch KM, Ricci BM, Hedayetullah NS, Jewell D, Kersey KE.
    Br J Clin Pharmacol; 2001 Nov; 52(5):596-600. PubMed ID: 11736869
    [Abstract] [Full Text] [Related]

  • 6. Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers.
    Peng WX, Li HD, Zhou HH.
    Eur J Clin Pharmacol; 2003 Jul; 59(3):237-41. PubMed ID: 12756512
    [Abstract] [Full Text] [Related]

  • 7. Effect of a newly developed ketolide antibiotic, telithromycin, on metabolism of theophylline and expression of cytochrome P450 in rats.
    Nosaka H, Nadai M, Kato M, Yasui K, Yoshizumi H, Miyoshi M, Zhao YL, Baba K, Takagi K, Hasegawa T.
    Life Sci; 2006 May 30; 79(1):50-6. PubMed ID: 16423372
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine.
    Lobo ED, Bergstrom RF, Reddy S, Quinlan T, Chappell J, Hong Q, Ring B, Knadler MP.
    Clin Pharmacokinet; 2008 May 30; 47(3):191-202. PubMed ID: 18307373
    [Abstract] [Full Text] [Related]

  • 9. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
    Orlando R, Padrini R, Perazzi M, De Martin S, Piccoli P, Palatini P.
    Clin Pharmacol Ther; 2006 May 30; 79(5):489-99. PubMed ID: 16678550
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic changes of unbound theophylline are due to plasma protein binding displacement and CYP1A2 activity inhibition by baicalin in rats.
    Gao N, Fang Y, Qi B, Jia LJ, Jin H, Qiao HL.
    J Ethnopharmacol; 2013 Nov 25; 150(2):477-84. PubMed ID: 24076258
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of antofloxacin hydrochloride in healthy male subjects after multiple intravenous dose administration.
    Wang J, Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Liang J, Zhang M, Li T.
    Xenobiotica; 2011 Jul 25; 41(7):561-6. PubMed ID: 21446836
    [Abstract] [Full Text] [Related]

  • 12. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.
    Macias WL, Bergstrom RF, Cerimele BJ, Kassahun K, Tatum DE, Callaghan JT.
    Pharmacotherapy; 1998 Jul 25; 18(6):1237-48. PubMed ID: 9855322
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of an extended-release theophylline product in cats.
    Guenther-Yenke CL, McKiernan BC, Papich MG, Powell E.
    J Am Vet Med Assoc; 2007 Sep 15; 231(6):900-6. PubMed ID: 17867974
    [Abstract] [Full Text] [Related]

  • 14. Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.
    Sohn JA, Kim HS, Oh J, Cho JY, Yu KS, Lee J, Shin SH, Lee JA, Choi CW, Kim EK, Kim BI, Park EA.
    Br J Clin Pharmacol; 2017 Jun 15; 83(6):1279-1286. PubMed ID: 27995649
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers.
    Lü Y, Kang ZS, Zhu Y, Zhang M, Liu Y, Zhang M, Li TY, Xiao YH.
    Chin Med J (Engl); 2011 Jan 15; 124(2):242-5. PubMed ID: 21362374
    [Abstract] [Full Text] [Related]

  • 16. The pharmacokinetics of antofloxacin in renally impaired rats.
    Pang XY, Liu L, Zhang DM, Wang GJ, Xie L, Liu XD.
    J Pharm Pharmacol; 2008 May 15; 60(5):667-70. PubMed ID: 18416945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers.
    Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Zhang M, Li T.
    Biopharm Drug Dispos; 2008 Apr 15; 29(3):167-72. PubMed ID: 18240275
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.